Wells Fargo’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.8K Buy
87,496
+3,245
+4% +$2.33K ﹤0.01% 5013
2025
Q1
$124K Buy
84,251
+1,686
+2% +$2.48K ﹤0.01% 4543
2024
Q4
$366K Buy
82,565
+17,595
+27% +$77.9K ﹤0.01% 3924
2024
Q3
$268K Buy
64,970
+1,353
+2% +$5.57K ﹤0.01% 4005
2024
Q2
$415K Buy
63,617
+12,327
+24% +$80.4K ﹤0.01% 3687
2024
Q1
$447K Buy
51,290
+6,860
+15% +$59.8K ﹤0.01% 3623
2023
Q4
$508K Sell
44,430
-150,708
-77% -$1.72M ﹤0.01% 3508
2023
Q3
$1.88M Buy
195,138
+4,611
+2% +$44.4K ﹤0.01% 2645
2023
Q2
$2.03M Buy
190,527
+48,077
+34% +$512K ﹤0.01% 2760
2023
Q1
$1.5M Buy
142,450
+47,551
+50% +$500K ﹤0.01% 2905
2022
Q4
$1.18M Sell
94,899
-7,438
-7% -$92.2K ﹤0.01% 2960
2022
Q3
$1.06M Sell
102,337
-141,530
-58% -$1.47M ﹤0.01% 3003
2022
Q2
$2.81M Sell
243,867
-304,914
-56% -$3.52M ﹤0.01% 2402
2022
Q1
$6.9M Sell
548,781
-43,419
-7% -$546K ﹤0.01% 2059
2021
Q4
$6.91M Sell
592,200
-704,839
-54% -$8.22M ﹤0.01% 2105
2021
Q3
$16.9M Buy
1,297,039
+336,513
+35% +$4.39M ﹤0.01% 1727
2021
Q2
$12.4M Buy
960,526
+407,825
+74% +$5.25M ﹤0.01% 1995
2021
Q1
$6.18M Buy
552,701
+147,556
+36% +$1.65M ﹤0.01% 2521
2020
Q4
$4.62M Sell
405,145
-31,529
-7% -$359K ﹤0.01% 2804
2020
Q3
$3.93M Sell
436,674
-9,293
-2% -$83.6K ﹤0.01% 2701
2020
Q2
$4.6M Buy
445,967
+113,364
+34% +$1.17M ﹤0.01% 2504
2020
Q1
$3.36M Sell
332,603
-4,109
-1% -$41.5K ﹤0.01% 2524
2019
Q4
$4.48M Buy
336,712
+40,361
+14% +$537K ﹤0.01% 2644
2019
Q3
$2.54M Buy
296,351
+20,275
+7% +$174K ﹤0.01% 3096
2019
Q2
$3.02M Sell
276,076
-80,636
-23% -$882K ﹤0.01% 2962
2019
Q1
$4.04M Buy
356,712
+55,366
+18% +$628K ﹤0.01% 2741
2018
Q4
$2.62M Buy
301,346
+206,273
+217% +$1.79M ﹤0.01% 3008
2018
Q3
$1.47M Sell
95,073
-13,606
-13% -$210K ﹤0.01% 3617
2018
Q2
$1.74M Sell
108,679
-154,136
-59% -$2.47M ﹤0.01% 3519
2018
Q1
$3.4M Buy
262,815
+16,629
+7% +$215K ﹤0.01% 2908
2017
Q4
$3.09M Buy
246,186
+48,050
+24% +$603K ﹤0.01% 2990
2017
Q3
$2.62M Buy
198,136
+73,479
+59% +$971K ﹤0.01% 3059
2017
Q2
$1.97M Buy
124,657
+9,719
+8% +$154K ﹤0.01% 3193
2017
Q1
$1.64M Buy
114,938
+288
+0.3% +$4.11K ﹤0.01% 3324
2016
Q4
$1.47M Buy
114,650
+51,981
+83% +$666K ﹤0.01% 3354
2016
Q3
$834K Buy
62,669
+900
+1% +$12K ﹤0.01% 3528
2016
Q2
$677K Sell
61,769
-2,510
-4% -$27.5K ﹤0.01% 3654
2016
Q1
$589K Buy
64,279
+6,414
+11% +$58.8K ﹤0.01% 3684
2015
Q4
$562K Buy
57,865
+10,315
+22% +$100K ﹤0.01% 3753
2015
Q3
$416K Sell
47,550
-124,232
-72% -$1.09M ﹤0.01% 3932
2015
Q2
$1.73M Buy
171,782
+16,412
+11% +$166K ﹤0.01% 3155
2015
Q1
$2.08M Sell
155,370
-26,647
-15% -$357K ﹤0.01% 2978
2014
Q4
$2.34M Buy
182,017
+17,093
+10% +$219K ﹤0.01% 2874
2014
Q3
$1.79M Buy
164,924
+96,668
+142% +$1.05M ﹤0.01% 3044
2014
Q2
$876K Sell
68,256
-6,853
-9% -$88K ﹤0.01% 3564
2014
Q1
$775K Sell
75,109
-444,870
-86% -$4.59M ﹤0.01% 3604
2013
Q4
$5.06M Buy
519,979
+422,438
+433% +$4.11M ﹤0.01% 2256
2013
Q3
$967K Buy
97,541
+1,671
+2% +$16.6K ﹤0.01% 3361
2013
Q2
$797K Buy
+95,870
New +$797K ﹤0.01% 3389